Arbet-Engels Christophe bought ALT
October 1, 2025 · Form 4 insider transaction
Arbet-Engels Christophe bought 150,000 shares of Altimmune, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderArbet-Engels Christophe
Role—
CompanyAltimmune, Inc. (ALT)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested; The RSUs become vested over four (4) years with 25% of the shares vesting October 1, 2026, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.